How To Win Over The EU CHMP At Virtual Meetings
The Pandemic Has Made Oral Explanations Trickier To Navigate
Executive Summary
Speakers at a recent RAPS meeting explained how companies should go about preparing for remote oral explanation meetings at the EMA, and why hybrid meetings with a mix of face-to-face and virtual presentations are likely to become the norm.
You may also be interested in...
The Stakes Are High So Get It Right: CHMP Oral Explanations & FDA AdComs
The stakes are extremely high for companies called before EU or US regulators and scientific experts to answer queries about their new drug applications at the later stages of the review process. How they perform is critical. Consultant Kate Dion has a raft of helpful tips for companies facing this daunting situation. Neena Brizmohun reports.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.